TANAKA Yoshiya

J-GLOBAL         Last updated: Jul 7, 2016 at 15:47
 
Avatar
Name
TANAKA Yoshiya
URL
http://www.uoeh-u.ac.jp/JP/hospital/introduction/sec_fac/001_001.html
Affiliation
University of Occupational and Environmental Health, Japan
Section
School of Medicine, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan
Job title
Professor and Chairman, Deputy Director of Hospital
Degree
(BLANK)

Research Areas

 
 

Education

 
 
 - 
1988
Graduate School, Division of Medicine, University of Occupational and Environmental Health, Japan
 
 
 - 
1984
Faculty of Medicine, University of Occupational and Environmental Health, Japan
 

Misc

 
CD31
Medical Immunology   24 552-562   1992
Osteoblasts are regulated by the cellular adhesion through ICAM-1 and VCAM-1.
J. Bone Miner. Res.   10 1462-1469   1995
Calcium dependent homotypic adhesion through LFA-1/ICAM-1 induces IL-1 and OTHrP prodution on adult T-cell leukemia cells in vitro.
Blood.   861,2257-2267    1995
Differential expression of integrin α6 and α4 determines pathways in human peripheral CD4+ T Cell differentiation.
Cell Adhesion and Communication   2 403-415   1994

Books etc

 
Regulation of leukocyte recruitment by proadhesive cytokines immobilized on endothelial proteoglycan. In Adhesion in leukocyte homing and differentiation.
Springer-Verlag (Curr. Top. Micro. lmmunol. )   1993   
T cell adhesion cascades : general considerations and illustrations with CD31. In Mechanisms of lymphocyte activation and immune regulation IV.
Plenum Press (Adv. Exp. Med. Biol. )   1993   
T cell adhesion molecules : relevance to autoimmunity. In The Molecular Pathology of Autoimmunity.
Harwood Academic Publishers   1993   

Research Grants & Projects

 
AMED: 
Project Year: Apr 2015       Investigator(s): TANAKA Yoshiya
Role of adhesion molecules and cytokines in the pathological mechanisms of systemic autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis, and metabolic bone diseases such as osteoporosis and diabetes mellitus
Development of pivotal therapeutic strategies for the treatment of systemic autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis, and metabolic bone diseases such as osteoporosis and diabetes mellitus